ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6651
0.00%
Brent Oil
82.865
0.02%
Bitcoin
69,199.08
-0.28%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Arch Therapeutics Inc (QB) (ARTHD)

  7. Arch Therapeutics Inc (QB) (ARTHD) Noticias

ARTHD

Arch Therapeutics (QB) (ARTHD)

Arch Therapeutics Inc (QB)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:ARTHD
FechaHoraFuenteTítuloSímboloCompañía
21/05/202415:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
09/05/202415:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ARTHDArch Therapeutics Inc (QB)
01/03/202415:30Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
15/02/202415:30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ARTHDArch Therapeutics Inc (QB)
22/01/202411:39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
29/12/202315:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:ARTHDArch Therapeutics Inc (QB)
05/10/202316:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
08/09/202316:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARTHDArch Therapeutics Inc (QB)
01/09/202315:30Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
22/08/202315:52Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
09/08/202310:16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:ARTHDArch Therapeutics Inc (QB)
22/06/202315:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHDArch Therapeutics Inc (QB)
23/05/202305:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHDArch Therapeutics Inc (QB)
16/05/202305:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARTHDArch Therapeutics Inc (QB)
25/01/202314:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARTHDArch Therapeutics Inc (QB)
23/01/202316:18Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHDArch Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:ARTHD

Su Consulta Reciente

NYSE
KO
Coca Cola
FX
EURMXN
Euro vs MXN
NYSE
DIS
Walt Disney
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
CCOM
US30
US 30
NYSE
MRK
Merck
NYSE
MCD
McDonalds
CCOM
US500
US 500
CCOM
OILBRENT
Brent Oil
CCOM
SILVER
SILVER
NYSE
VZ
Verizon Communications
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados